Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Maurizio Zangari

Concepts (496)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma
149
2025
2998
10.200
Why?
Thalidomide
33
2016
378
2.970
Why?
Boronic Acids
17
2013
183
2.830
Why?
Pyrazines
17
2013
188
2.830
Why?
Hematopoietic Stem Cell Transplantation
22
2024
578
2.050
Why?
Bone Marrow
17
2022
363
1.900
Why?
Venous Thrombosis
8
2009
87
1.710
Why?
Antineoplastic Combined Chemotherapy Protocols
31
2024
1000
1.680
Why?
Paraproteinemias
7
2022
72
1.610
Why?
Angiogenesis Inhibitors
12
2009
183
1.540
Why?
Humans
163
2025
50503
1.390
Why?
Protease Inhibitors
7
2011
58
1.340
Why?
Chromosomes, Human, Pair 1
7
2023
92
1.310
Why?
Proteasome Inhibitors
6
2016
104
1.260
Why?
Antibodies, Bispecific
6
2025
88
1.190
Why?
Prognosis
40
2024
1978
1.190
Why?
Antineoplastic Agents
20
2024
1172
1.180
Why?
Middle Aged
67
2025
12611
1.170
Why?
Aged
64
2025
9741
1.170
Why?
Alkaline Phosphatase
7
2020
93
1.150
Why?
Neoplasm, Residual
6
2022
160
1.130
Why?
Transplantation, Autologous
30
2024
481
1.100
Why?
Thrombosis
6
2013
250
1.050
Why?
Bone Remodeling
3
2016
149
1.030
Why?
Bone Diseases
2
2021
96
1.030
Why?
Male
74
2025
25907
0.940
Why?
Osteogenesis
4
2018
356
0.930
Why?
Female
73
2025
27081
0.920
Why?
Immunologic Factors
5
2016
111
0.900
Why?
Gene Expression Profiling
21
2023
1025
0.880
Why?
Anticoagulants
6
2009
256
0.830
Why?
Peripheral Blood Stem Cell Transplantation
6
2012
56
0.820
Why?
Melphalan
12
2016
178
0.810
Why?
Neoplasms, Plasma Cell
4
2024
36
0.810
Why?
Activated Protein C Resistance
4
2011
10
0.780
Why?
Monoclonal Gammopathy of Undetermined Significance
8
2024
112
0.770
Why?
Parathyroid Hormone
4
2018
149
0.740
Why?
Venous Thromboembolism
3
2011
74
0.730
Why?
Antibodies, Monoclonal
4
2022
462
0.730
Why?
Adult
42
2025
13577
0.720
Why?
Durapatite
1
2020
24
0.690
Why?
B-Cell Maturation Antigen
7
2025
99
0.690
Why?
Disease-Free Survival
21
2019
444
0.670
Why?
Gene Amplification
1
2019
56
0.660
Why?
Survival Rate
21
2020
909
0.660
Why?
Neoplasm Proteins
7
2020
320
0.660
Why?
Thromboembolism
3
2009
55
0.660
Why?
Dexamethasone
14
2024
432
0.650
Why?
Myeloablative Agonists
4
2012
32
0.640
Why?
Retrospective Studies
25
2025
6263
0.630
Why?
Aged, 80 and over
21
2025
3226
0.630
Why?
Bone and Bones
4
2021
478
0.610
Why?
Gene Expression Regulation, Neoplastic
12
2021
833
0.610
Why?
Factor V
4
2011
11
0.600
Why?
Oligopeptides
3
2018
95
0.600
Why?
Spinal Fractures
1
2018
38
0.600
Why?
Thymus Gland
1
2018
42
0.590
Why?
Stem Cell Transplantation
12
2024
179
0.580
Why?
Treatment Outcome
32
2024
5283
0.580
Why?
Parathyroidectomy
1
2018
46
0.580
Why?
Thyroidectomy
1
2018
60
0.570
Why?
Translocation, Genetic
8
2021
240
0.570
Why?
Disease Progression
16
2023
829
0.570
Why?
Clinical Trials as Topic
9
2022
486
0.560
Why?
Chromosome Aberrations
11
2023
280
0.560
Why?
Survival Analysis
14
2024
661
0.550
Why?
Calcification, Physiologic
1
2017
40
0.550
Why?
Pelvis
1
2017
66
0.540
Why?
Follow-Up Studies
22
2024
2242
0.540
Why?
Risk Factors
23
2024
3724
0.540
Why?
Osteoblasts
6
2020
462
0.530
Why?
Thrombophilia
4
2009
18
0.520
Why?
Tumor Microenvironment
5
2024
222
0.500
Why?
Chromosome Deletion
6
2023
134
0.490
Why?
Plasma Cells
9
2023
221
0.480
Why?
Drug Resistance, Neoplasm
7
2015
316
0.480
Why?
Animals
19
2024
13124
0.470
Why?
Neoplasms
3
2009
1251
0.470
Why?
Transplantation Conditioning
7
2019
87
0.460
Why?
Neoplasm Recurrence, Local
7
2024
629
0.440
Why?
Receptor, Parathyroid Hormone, Type 1
1
2013
24
0.440
Why?
Polycythemia Vera
1
2013
6
0.430
Why?
Hemostasis
3
2008
59
0.420
Why?
Neovascularization, Pathologic
4
2009
155
0.420
Why?
Mutation
6
2022
1280
0.400
Why?
Combined Modality Therapy
17
2024
641
0.400
Why?
Neutropenia
2
2023
116
0.390
Why?
Hematopoietic Stem Cells
2
2012
197
0.370
Why?
Bone Neoplasms
2
2010
179
0.360
Why?
Amyloidosis
3
2009
81
0.350
Why?
Evolution, Molecular
2
2021
95
0.350
Why?
Doxorubicin
7
2009
236
0.350
Why?
Immunotherapy, Adoptive
4
2024
163
0.330
Why?
Mice
11
2024
5687
0.330
Why?
Anti-Anxiety Agents
1
2009
34
0.320
Why?
In Situ Hybridization, Fluorescence
7
2023
231
0.320
Why?
Kaplan-Meier Estimate
10
2019
464
0.320
Why?
Hemorrhagic Disorders
1
2009
5
0.320
Why?
Cryoglobulinemia
1
2008
13
0.310
Why?
Biopsy, Needle
1
2009
178
0.310
Why?
Pain
2
2009
387
0.300
Why?
Recurrence
11
2024
659
0.300
Why?
Analgesics
1
2009
116
0.300
Why?
Collagen
2
2020
204
0.300
Why?
Pulmonary Embolism
1
2009
99
0.300
Why?
Risk Assessment
7
2023
1270
0.290
Why?
Hematologic Neoplasms
2
2022
99
0.280
Why?
Cell Line, Tumor
4
2023
1398
0.280
Why?
Farnesyltranstransferase
1
2006
5
0.280
Why?
Vascular Endothelial Growth Factor Receptor-2
2
2004
30
0.280
Why?
Osteolysis
2
2022
74
0.270
Why?
Waldenstrom Macroglobulinemia
2
2022
40
0.270
Why?
Pyrroles
2
2004
68
0.270
Why?
Cell Differentiation
4
2022
640
0.270
Why?
Risk
4
2014
324
0.270
Why?
Neoplasms, Second Primary
2
2024
74
0.260
Why?
Cell Proliferation
8
2023
985
0.260
Why?
Sirolimus
1
2006
62
0.260
Why?
Time Factors
11
2021
2935
0.260
Why?
Logistic Models
5
2018
900
0.260
Why?
Signal Transduction
6
2021
1624
0.260
Why?
Chromosomes, Human, Pair 17
2
2017
34
0.250
Why?
Fluorodeoxyglucose F18
4
2021
189
0.240
Why?
Plasmacytoma
2
2020
42
0.230
Why?
Immunoglobulins, Intravenous
1
2025
65
0.230
Why?
Polycomb Repressive Complex 2
2
2021
46
0.230
Why?
Enoxaparin
1
2004
31
0.230
Why?
Remission Induction
10
2021
208
0.230
Why?
Indoles
2
2004
278
0.230
Why?
Vascular Endothelial Growth Factor A
2
2004
182
0.220
Why?
Prospective Studies
9
2019
2378
0.210
Why?
Blood Coagulation
1
2003
60
0.210
Why?
Positron-Emission Tomography
3
2022
292
0.210
Why?
Bone Resorption
2
2022
302
0.200
Why?
Proto-Oncogene Proteins B-raf
2
2020
80
0.200
Why?
Hematopoietic Stem Cell Mobilization
3
2008
58
0.200
Why?
Immunoglobulin Light Chains
2
2017
84
0.200
Why?
Randomized Controlled Trials as Topic
3
2012
573
0.200
Why?
Immunoconjugates
1
2022
38
0.190
Why?
Drug Approval
1
2022
47
0.190
Why?
Cell Cycle
2
2021
226
0.190
Why?
Hemorrhage
3
2009
197
0.190
Why?
Lymphoma, B-Cell
1
2022
49
0.190
Why?
Chromosomal Instability
2
2019
16
0.190
Why?
Epigenomics
1
2021
68
0.190
Why?
Chromosomes, Human, Pair 13
5
2008
34
0.190
Why?
Patient Participation
1
2022
70
0.190
Why?
SOXC Transcription Factors
1
2021
13
0.180
Why?
T-Lymphocytes
4
2024
325
0.180
Why?
Arkansas
5
2021
1985
0.180
Why?
Diffusion Magnetic Resonance Imaging
2
2019
125
0.180
Why?
Odontoblasts
1
2020
4
0.180
Why?
Calcium Phosphates
1
2020
5
0.180
Why?
HL-60 Cells
1
2020
18
0.180
Why?
U937 Cells
1
2020
14
0.180
Why?
Etoposide
5
2009
77
0.180
Why?
K562 Cells
1
2020
40
0.180
Why?
Kidney Diseases
2
2020
213
0.180
Why?
Genes, Tumor Suppressor
2
2021
73
0.180
Why?
NIH 3T3 Cells
1
2020
51
0.170
Why?
Mammals
1
2020
50
0.170
Why?
MCF-7 Cells
1
2020
62
0.170
Why?
Practice Guidelines as Topic
1
2023
468
0.170
Why?
Exosome Multienzyme Ribonuclease Complex
1
2020
12
0.170
Why?
Leukemia, Plasma Cell
1
2020
32
0.170
Why?
Protein C
2
2011
18
0.170
Why?
Myelodysplastic Syndromes
3
2007
78
0.170
Why?
beta 2-Microglobulin
5
2008
39
0.170
Why?
HEK293 Cells
1
2020
213
0.170
Why?
Busulfan
1
2019
19
0.170
Why?
Cisplatin
6
2009
286
0.170
Why?
HeLa Cells
1
2020
247
0.170
Why?
Gene Regulatory Networks
1
2020
106
0.160
Why?
Atrial Fibrillation
1
2022
188
0.160
Why?
Hematopoiesis, Extramedullary
1
2019
9
0.160
Why?
Epigenesis, Genetic
2
2020
372
0.160
Why?
Imaging, Three-Dimensional
2
2017
150
0.160
Why?
Genome-Wide Association Study
1
2020
163
0.160
Why?
Insulin-Like Growth Factor Binding Protein 2
1
2018
10
0.160
Why?
Healthcare Disparities
1
2022
281
0.160
Why?
Fractures, Compression
1
2018
17
0.150
Why?
Predictive Value of Tests
4
2009
930
0.150
Why?
Spleen
1
2019
169
0.150
Why?
Genomic Instability
2
2016
90
0.150
Why?
Fibrinolysis
2
2009
5
0.150
Why?
Phosphotransferases
1
2018
16
0.150
Why?
Blood Coagulation Factors
2
2009
17
0.150
Why?
Cytokines
3
2007
606
0.150
Why?
Antineoplastic Agents, Alkylating
6
2008
73
0.150
Why?
Bacteremia
1
2019
89
0.150
Why?
Adipocytes
1
2018
126
0.140
Why?
Cell Line
1
2020
988
0.140
Why?
Gene Rearrangement
1
2018
65
0.140
Why?
Cluster Analysis
4
2012
219
0.140
Why?
Metaphase
4
2016
45
0.140
Why?
Hexokinase
1
2017
17
0.140
Why?
Heparin, Low-Molecular-Weight
2
2007
21
0.140
Why?
Ultrasonography, Doppler
2
2007
41
0.140
Why?
Renal Insufficiency
4
2010
110
0.130
Why?
Fibrinolytic Agents
2
2007
125
0.130
Why?
Clonal Evolution
1
2016
56
0.130
Why?
Calcium
1
2018
398
0.130
Why?
Gene Expression Regulation, Enzymologic
1
2017
179
0.130
Why?
Tumor Burden
3
2020
130
0.130
Why?
Gene Expression
1
2018
610
0.120
Why?
Disease Models, Animal
4
2016
1436
0.120
Why?
Tumor Suppressor Protein p53
1
2017
213
0.120
Why?
Immunotherapy
2
2016
235
0.120
Why?
Multivariate Analysis
7
2021
583
0.120
Why?
Genes, Neoplasm
1
2015
27
0.120
Why?
Polymorphism, Single Nucleotide
2
2020
475
0.120
Why?
Bone Marrow Transplantation
4
2022
136
0.120
Why?
Gene Dosage
1
2015
74
0.120
Why?
Salvage Therapy
6
2006
137
0.120
Why?
Incidence
2
2009
1032
0.120
Why?
Algorithms
1
2018
625
0.120
Why?
Osteoclasts
3
2022
427
0.110
Why?
Cystatin M
2
2024
19
0.110
Why?
Case-Control Studies
4
2011
1156
0.110
Why?
Altitude
1
2013
16
0.110
Why?
Chromosomes, Human, Pair 11
3
2020
49
0.110
Why?
Janus Kinase 2
1
2013
22
0.110
Why?
Cross-Sectional Studies
3
2023
1610
0.100
Why?
STAT3 Transcription Factor
2
2010
77
0.100
Why?
Tomography, X-Ray Computed
2
2017
1164
0.100
Why?
Models, Biological
1
2016
716
0.100
Why?
Protein-Tyrosine Kinases
3
2018
88
0.100
Why?
Bone Density Conservation Agents
2
2010
74
0.100
Why?
Mice, Inbred C57BL
1
2018
1808
0.100
Why?
Creatinine
2
2010
145
0.100
Why?
Cytogenetic Analysis
6
2014
74
0.100
Why?
Viremia
1
2012
22
0.100
Why?
Clone Cells
2
2023
70
0.100
Why?
Cytomegalovirus Infections
1
2012
38
0.100
Why?
Models, Genetic
2
2016
172
0.100
Why?
Clinical Trials, Phase II as Topic
1
2012
45
0.100
Why?
Clinical Trials, Phase III as Topic
1
2012
45
0.100
Why?
Viper Venoms
1
2011
7
0.090
Why?
Drug Evaluation, Preclinical
1
2012
145
0.090
Why?
Epidemiologic Methods
2
2008
46
0.090
Why?
NF-kappa B
2
2018
315
0.090
Why?
Receptors, TNF-Related Apoptosis-Inducing Ligand
1
2010
5
0.090
Why?
Arsenicals
1
2010
14
0.090
Why?
TNF-Related Apoptosis-Inducing Ligand
1
2010
20
0.090
Why?
Oxides
1
2010
18
0.090
Why?
Mutation Rate
2
2021
35
0.090
Why?
Granulocyte Colony-Stimulating Factor
2
2008
63
0.090
Why?
Hypercalcemia
1
2010
33
0.090
Why?
Transplantation, Homologous
4
2003
145
0.090
Why?
Cyclophosphamide
4
2003
168
0.090
Why?
Janus Kinase 1
1
2010
16
0.090
Why?
Anemia
1
2010
67
0.090
Why?
Antineoplastic Agents, Hormonal
2
2007
49
0.090
Why?
MAP Kinase Kinase 1
1
2010
23
0.090
Why?
Cyclin-Dependent Kinases
1
2010
26
0.090
Why?
Administration, Oral
2
2009
434
0.090
Why?
Proteinuria
1
2010
37
0.090
Why?
Alleles
2
2021
256
0.080
Why?
Extracellular Signal-Regulated MAP Kinases
1
2010
80
0.080
Why?
Genomics
2
2023
279
0.080
Why?
Diphosphonates
1
2010
90
0.080
Why?
Lorazepam
1
2009
12
0.080
Why?
Receptors, Retinoic Acid
1
2009
22
0.080
Why?
Anesthesia, Local
1
2009
16
0.080
Why?
Dose-Response Relationship, Drug
3
2008
1372
0.080
Why?
Oxycodone
1
2009
27
0.080
Why?
Hyperhomocysteinemia
1
2009
30
0.080
Why?
Prednisone
1
2009
101
0.080
Why?
Tretinoin
1
2009
50
0.080
Why?
Histones
2
2021
297
0.080
Why?
Hemostatic Techniques
1
2009
29
0.080
Why?
Plasma Exchange
1
2009
25
0.080
Why?
Vasculitis
1
2008
29
0.080
Why?
Vincristine
3
2003
82
0.080
Why?
Syndecan-1
3
2021
75
0.080
Why?
Transcription Factors
2
2023
565
0.080
Why?
Biopsy
3
2018
588
0.080
Why?
Carrier Proteins
1
2010
298
0.080
Why?
Drug Therapy, Combination
1
2009
384
0.080
Why?
DNA Copy Number Variations
2
2021
109
0.080
Why?
Cytogenetics
1
2008
21
0.080
Why?
Bone Development
1
2009
65
0.080
Why?
Radiopharmaceuticals
2
2021
204
0.080
Why?
Platelet Aggregation
1
2008
70
0.070
Why?
Staphylococcal Infections
2
2019
267
0.070
Why?
Pain Measurement
1
2009
270
0.070
Why?
Thrombocytopenia
1
2009
81
0.070
Why?
Double-Blind Method
1
2009
708
0.070
Why?
Brain Diseases, Metabolic
1
2007
4
0.070
Why?
Phlebography
1
2007
60
0.070
Why?
Hyperammonemia
1
2007
22
0.070
Why?
Myeloma Proteins
1
2007
26
0.070
Why?
Antimetabolites
1
2006
12
0.070
Why?
Cell Communication
2
2023
68
0.070
Why?
Chi-Square Distribution
1
2007
277
0.070
Why?
Transcriptome
2
2020
313
0.070
Why?
Partial Thromboplastin Time
1
2006
12
0.070
Why?
Magnetic Resonance Imaging
4
2007
1548
0.070
Why?
Osteoprotegerin
1
2006
54
0.070
Why?
Heterozygote
1
2006
83
0.070
Why?
Acetaminophen
1
2009
276
0.070
Why?
Antibiotics, Antineoplastic
1
2006
77
0.060
Why?
Gastrointestinal Neoplasms
1
2006
40
0.060
Why?
Models, Statistical
1
2007
226
0.060
Why?
Pilot Projects
1
2008
698
0.060
Why?
Age Factors
3
2005
1110
0.060
Why?
Femur Head Necrosis
1
2005
18
0.060
Why?
Neovascularization, Physiologic
1
2005
68
0.060
Why?
Apoptosis
1
2010
1097
0.060
Why?
Gene Deletion
2
2003
261
0.060
Why?
Syndrome
2
2019
240
0.060
Why?
Killer Cells, Natural
1
2024
106
0.060
Why?
Ferritins
1
2024
30
0.060
Why?
Demography
1
2024
94
0.060
Why?
Glucuronidase
1
2003
48
0.060
Why?
Myeloid Progenitor Cells
1
2023
17
0.060
Why?
X-Ray Microtomography
1
2024
79
0.060
Why?
DNA Methylation
2
2020
550
0.050
Why?
CD8-Positive T-Lymphocytes
1
2024
125
0.050
Why?
Receptors, G-Protein-Coupled
1
2024
49
0.050
Why?
Immunosuppressive Agents
1
2005
225
0.050
Why?
DNA, Neoplasm
2
2020
143
0.050
Why?
Antibodies
1
2024
153
0.050
Why?
Discitis
1
2003
11
0.050
Why?
Oligonucleotide Array Sequence Analysis
4
2006
405
0.050
Why?
Myeloproliferative Disorders
1
2003
28
0.050
Why?
Antigens, CD34
1
2003
75
0.050
Why?
TNF Receptor-Associated Factor 3
1
2022
13
0.050
Why?
Tumor Cells, Cultured
3
2010
457
0.050
Why?
Platelet Count
3
2008
65
0.050
Why?
Patients
1
2022
48
0.050
Why?
Rats
1
2009
3292
0.050
Why?
Geography
1
2022
60
0.050
Why?
Leukemia, Myeloid
1
2002
44
0.050
Why?
Myeloid Differentiation Factor 88
1
2022
32
0.050
Why?
Receptors, Antigen, T-Cell
1
2022
48
0.050
Why?
Drug Interactions
1
2002
206
0.050
Why?
Patient Selection
1
2023
259
0.050
Why?
Chromosome Disorders
1
2002
34
0.050
Why?
United States Food and Drug Administration
1
2022
90
0.050
Why?
Oncogenes
1
2021
57
0.050
Why?
Enzyme Inhibitors
1
2004
377
0.050
Why?
Phylogeny
1
2022
236
0.050
Why?
Central Nervous System Neoplasms
1
2002
63
0.050
Why?
Hypothyroidism
1
2002
56
0.050
Why?
RANK Ligand
1
2022
187
0.050
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2022
81
0.050
Why?
Transcriptional Activation
1
2021
119
0.050
Why?
Lymphoma, Large B-Cell, Diffuse
1
2022
90
0.050
Why?
Cohort Studies
2
2020
1452
0.050
Why?
Chromatin
1
2021
137
0.050
Why?
Antibodies, Monoclonal, Humanized
1
2022
226
0.040
Why?
Pyrimidines
1
2022
191
0.040
Why?
Proto-Oncogene Proteins p21(ras)
1
2021
67
0.040
Why?
Cyclin D2
1
2020
20
0.040
Why?
Aneuploidy
1
2020
18
0.040
Why?
Endothelium, Vascular
1
2002
251
0.040
Why?
Proto-Oncogene Proteins c-maf
1
2020
19
0.040
Why?
Chromosomes, Human, Pair 4
1
2020
30
0.040
Why?
Histone Code
1
2020
30
0.040
Why?
Gene Expression Regulation, Leukemic
1
2020
29
0.040
Why?
Cyclin D1
1
2020
52
0.040
Why?
ras Proteins
1
2020
64
0.040
Why?
Genome, Human
1
2021
109
0.040
Why?
Protein Kinase Inhibitors
1
2022
204
0.040
Why?
Chromosomes, Human, Pair 14
1
2020
66
0.040
Why?
Longitudinal Studies
2
2016
735
0.040
Why?
Transcriptional Elongation Factors
1
2020
17
0.040
Why?
Genetic Loci
1
2020
45
0.040
Why?
Postoperative Complications
1
2007
1033
0.040
Why?
RNA, Messenger
3
2010
1089
0.040
Why?
Health Status Disparities
1
2022
202
0.040
Why?
Genetic Variation
1
2020
207
0.040
Why?
DNA Mutational Analysis
1
2020
175
0.040
Why?
High-Throughput Nucleotide Sequencing
1
2020
169
0.040
Why?
Neoplastic Stem Cells
2
2015
98
0.040
Why?
Gram-Positive Bacterial Infections
1
2019
27
0.040
Why?
Computational Biology
1
2020
215
0.040
Why?
Pseudomonas Infections
1
2019
48
0.040
Why?
Proline
1
2018
30
0.040
Why?
Bone Marrow Cells
2
2014
196
0.040
Why?
DNA-Binding Proteins
1
2021
418
0.040
Why?
Recombinant Proteins
2
2010
476
0.040
Why?
Promoter Regions, Genetic
1
2020
465
0.040
Why?
Fluorescent Dyes
1
2018
103
0.040
Why?
Receptor Protein-Tyrosine Kinases
1
2018
46
0.040
Why?
Proteolysis
1
2018
96
0.040
Why?
Oncogene Proteins, Fusion
1
2018
57
0.040
Why?
Extracellular Matrix
1
2018
109
0.040
Why?
Cell Movement
1
2018
247
0.040
Why?
Kidney Function Tests
1
2017
51
0.040
Why?
False Positive Reactions
1
2017
59
0.030
Why?
Glomerular Filtration Rate
1
2017
119
0.030
Why?
Amino Acid Sequence
1
2018
574
0.030
Why?
Genetic Predisposition to Disease
1
2020
511
0.030
Why?
Cell Survival
2
2010
589
0.030
Why?
Genes, ras
1
2016
43
0.030
Why?
Genes, p53
1
2016
49
0.030
Why?
Mice, SCID
2
2009
178
0.030
Why?
Glycolysis
1
2016
69
0.030
Why?
Chromosome Mapping
2
2006
153
0.030
Why?
Image Interpretation, Computer-Assisted
1
2016
105
0.030
Why?
Phosphatidylinositol 3-Kinases
1
2016
140
0.030
Why?
Serum Albumin
2
2008
57
0.030
Why?
Syndecans
2
2006
37
0.030
Why?
Proteoglycans
2
2006
83
0.030
Why?
Cells, Cultured
1
2018
1571
0.030
Why?
Drug Monitoring
1
2015
79
0.030
Why?
Myocardium
1
2017
445
0.030
Why?
Interspersed Repetitive Sequences
1
2014
8
0.030
Why?
Karyotype
1
2014
17
0.030
Why?
Proportional Hazards Models
2
2006
415
0.030
Why?
Membrane Glycoproteins
2
2006
245
0.030
Why?
Transplantation Chimera
2
2003
14
0.030
Why?
Neoplasm Staging
2
2007
746
0.030
Why?
Infusions, Intravenous
2
2003
213
0.030
Why?
RNA Interference
1
2013
178
0.020
Why?
Cytomegalovirus
1
2012
28
0.020
Why?
Viral Load
1
2012
76
0.020
Why?
Virus Activation
1
2012
37
0.020
Why?
Graft vs Host Disease
2
2003
84
0.020
Why?
United States
1
2022
4955
0.020
Why?
Interferon Regulatory Factor-1
1
2010
14
0.020
Why?
Cell Growth Processes
1
2010
22
0.020
Why?
Antiviral Agents
1
2012
170
0.020
Why?
CDC2-CDC28 Kinases
1
2010
11
0.020
Why?
Femur
1
2010
130
0.020
Why?
Long-Term Care
1
2010
50
0.020
Why?
Peripheral Nervous System Diseases
1
2010
58
0.020
Why?
RNA, Small Interfering
1
2010
208
0.020
Why?
Down-Regulation
1
2010
340
0.020
Why?
Bone Diseases, Metabolic
1
2010
74
0.020
Why?
Cell Transformation, Neoplastic
1
2010
181
0.020
Why?
Abnormalities, Multiple
1
2010
167
0.020
Why?
Protein Isoforms
1
2009
116
0.020
Why?
Ploidies
1
2008
11
0.020
Why?
Ligands
1
2009
203
0.020
Why?
Polyethylene Glycols
1
2008
86
0.020
Why?
Rabbits
1
2009
372
0.020
Why?
Hemoglobins
1
2008
109
0.020
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2009
572
0.020
Why?
Age Distribution
1
2007
170
0.020
Why?
C-Reactive Protein
1
2008
144
0.020
Why?
Ammonia
1
2007
78
0.020
Why?
Diagnosis, Differential
1
2010
1033
0.020
Why?
Mass Screening
1
2010
344
0.020
Why?
Multigene Family
1
2006
54
0.020
Why?
Blood Proteins
1
2007
84
0.020
Why?
Brain
2
2007
1319
0.020
Why?
Bone Density
1
2009
386
0.020
Why?
Cyclin D
1
2006
18
0.020
Why?
Cyclins
1
2006
38
0.020
Why?
RNA, Neoplasm
1
2006
43
0.020
Why?
Evidence-Based Medicine
1
2007
253
0.020
Why?
Leukemia, Myeloid, Acute
1
2007
181
0.020
Why?
Radiography
1
2007
485
0.020
Why?
Coculture Techniques
1
2006
142
0.020
Why?
Data Interpretation, Statistical
1
2006
162
0.020
Why?
Neoplasms, Experimental
1
2006
110
0.020
Why?
Interferon-alpha
1
2005
47
0.020
Why?
Survivors
1
2006
128
0.020
Why?
Databases, Factual
1
2007
673
0.010
Why?
Mice, Transgenic
1
2006
540
0.010
Why?
Monosomy
1
2003
5
0.010
Why?
Odds Ratio
1
2005
551
0.010
Why?
Trisomy
1
2003
27
0.010
Why?
History, 21st Century
1
2003
56
0.010
Why?
Endothelial Growth Factors
1
2003
9
0.010
Why?
Vascular Endothelial Growth Factors
1
2003
13
0.010
Why?
Lymphokines
1
2003
19
0.010
Why?
Fusion Proteins, bcr-abl
1
2003
17
0.010
Why?
Stem Cell Factor
1
2003
7
0.010
Why?
History, 20th Century
1
2003
100
0.010
Why?
Confidence Intervals
1
2003
154
0.010
Why?
Probability
1
2003
164
0.010
Why?
Lymphocyte Transfusion
1
2003
12
0.010
Why?
Interphase
1
2003
9
0.010
Why?
Diploidy
1
2003
26
0.010
Why?
Leukocyte Count
1
2003
69
0.010
Why?
Back Pain
1
2003
38
0.010
Why?
Interferons
1
2002
38
0.010
Why?
Sex Factors
1
2005
712
0.010
Why?
Intercellular Signaling Peptides and Proteins
1
2003
102
0.010
Why?
Cell Count
1
2003
150
0.010
Why?
Drug Administration Schedule
1
2003
370
0.010
Why?
Thyroid Function Tests
1
2002
25
0.010
Why?
Thyrotropin
1
2002
49
0.010
Why?
Prevalence
1
2005
971
0.010
Why?
Neutrophils
1
2003
145
0.010
Why?
Fatal Outcome
1
2002
197
0.010
Why?
Tissue Donors
1
2003
121
0.010
Why?
Cell Division
1
2002
291
0.010
Why?
Reoperation
1
2003
460
0.010
Why?
Acute Disease
1
2002
373
0.010
Why?
Up-Regulation
1
2002
446
0.010
Why?
Anti-Bacterial Agents
1
2003
745
0.010
Why?
Zangari's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description